Real-time enrollment status for this inflammatory bowel disease clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 1:57 AM UTC
| NCT Number | NCT07113522 |
| Recruiting Status | Recruiting |
| Condition | Inflammatory Bowel Disease |
| Phase | PHASE2 |
| Target Enrollment | 140 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Mirador Therapeutics, Inc. |
| Last Updated on CT.gov | March 12, 2026 (Mar 12, 2026) |
As of August 31, 2026: Clinical trial NCT07113522 is currently recruiting participants. This phase2 study for inflammatory bowel disease is actively seeking new participants at 46 locations across the United States. The study is sponsored by Mirador Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07113522 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07113522 was last updated Mar 12, 2026 (March 12, 2026). HelloStudys verifies this status automatically.